MoodCalmer™ for low mood depression

MoodCalmer™ is web-based and derived from an earlier program called COPE. In an open multi-site trial across two continents, COPE was shown to:

  • Reduce depression severity by 41% in all participants enrolled.
  • Reduce depression severity by 52% in completers.
  • Have high levels of patient satisfaction with 68% completing the program.

The program helps users develop long-lasting improvements in depression by teaching them new cognitive and behavioral skills.